Literature DB >> 35508709

Bulsufan decreases the incidence of mixed chimaerism in HLA-matched donor transplantation for severe aplastic anaemia.

Lan-Ping Xu1,2, Zheng-Li Xu1,2, Yuan-Yuan Zhang1,2, Yi-Fei Cheng1,2, Xiao-Dong Mo1,2, Ting-Ting Han1,2, Feng-Rong Wang1,2, Chen-Hua Yan1,2, Yu-Qian Sun1,2, Yu-Hong Chen1,2, Fei-Fei Tang1,2, Wei Han1,2, Yu Wang1,2, Xiao-Hui Zhang1,2, Kai-Yan Liu1,2, Xiao-Jun Huang3,4,5,6.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35508709     DOI： 10.1038/s41409-022-01682-x

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.174


× No keyword cloud information.
  5 in total

1.  Optimizing conditioning regimen with low-dose irradiation or busulfan enables the outcome of transplantation from a 6-7/8 HLA-matched donor comparable to that from an 8/8 HLA-matched unrelated donor in severe aplastic anemia patients under 40 years.

Authors:  Xia Qin; Yi-Ping Zhu; Cheng-Juan Luo; Ming Zhou; Ke Huang; Chun Chen; Wei-Ping Zhang; Yuan Sun; Rong-Mu Luo; Xiang-Feng Tang; Ting Yang; Xian-Min Song; Shao-Yan Hu; Zi-Min Sun; Jiong Hu; Shun-Qing Wang; Jing Chen
Journal:  Ann Hematol       Date:  2021-05-14       Impact factor: 3.673

2.  Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis.

Authors:  Imke H Bartelink; Arief Lalmohamed; Elisabeth M L van Reij; Christopher C Dvorak; Rada M Savic; Juliette Zwaveling; Robbert G M Bredius; Antoine C G Egberts; Marc Bierings; Morris Kletzel; Peter J Shaw; Christa E Nath; George Hempel; Marc Ansari; Maja Krajinovic; Yves Théorêt; Michel Duval; Ron J Keizer; Henrique Bittencourt; Moustapha Hassan; Tayfun Güngör; Robert F Wynn; Paul Veys; Geoff D E Cuvelier; Sarah Marktel; Robert Chiesa; Morton J Cowan; Mary A Slatter; Melisa K Stricherz; Cathryn Jennissen; Janel R Long-Boyle; Jaap Jan Boelens
Journal:  Lancet Haematol       Date:  2016-10-13       Impact factor: 18.959

3.  Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.

Authors:  Nelli Bejanyan; Soyoung Kim; Kyle M Hebert; Natasha Kekre; Hisham Abdel-Azim; Ibrahim Ahmed; Mahmoud Aljurf; Sherif M Badawy; Amer Beitinjaneh; Jaap Jan Boelens; Miguel Angel Diaz; Christopher C Dvorak; Shahinaz Gadalla; James Gajewski; Robert Peter Gale; Siddhartha Ganguly; Andrew R Gennery; Biju George; Usama Gergis; David Gómez-Almaguer; Marta Gonzalez Vicent; Hasan Hashem; Rammurti T Kamble; Kimberly A Kasow; Hillard M Lazarus; Vikram Mathews; Paul J Orchard; Michael Pulsipher; Olle Ringden; Kirk Schultz; Pierre Teira; Ann E Woolfrey; Blachy Dávila Saldaña; Bipin Savani; Jacek Winiarski; Jean Yared; Daniel J Weisdorf; Joseph H Antin; Mary Eapen
Journal:  Blood Adv       Date:  2019-10-22

Review 4.  Aplastic Anemia.

Authors:  Neal S Young
Journal:  N Engl J Med       Date:  2018-10-25       Impact factor: 91.245

Review 5.  Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment.

Authors:  George E Georges; Kris Doney; Rainer Storb
Journal:  Blood Adv       Date:  2018-08-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.